============================================================
QUALITATIVE ERROR ANALYSIS REPORT
Generated on: 2025-08-21 14:54:21
Model: GPT-4o
Dataset: Kegg
============================================================

1. BASIC PERFORMANCE METRICS:
   Accuracy: 0.937
   Precision: 0.917
   Sensitivity: 0.962
   F1-Score: 0.939
   Total samples: 13262
   TP: 6378, TN: 6053, FP: 578, FN: 253

2. SMILES COMPLEXITY ANALYSIS:
   False Positives: 578 cases
     Avg combined SMILES length: 124.7 ± 106.9
   False Negatives: 253 cases
     Avg combined SMILES length: 197.7 ± 227.8
   True Positives: 6378 cases
     Avg combined SMILES length: 159.5 ± 143.2
   True Negatives: 6053 cases
     Avg combined SMILES length: 115.0 ± 73.3

3. GENE TARGET COMPLEXITY ANALYSIS:
   False Positives: 578 cases
     Avg combined gene targets: 9.5 ± 17.6
   False Negatives: 253 cases
     Avg combined gene targets: 9.8 ± 12.8
   True Positives: 6378 cases
     Avg combined gene targets: 9.5 ± 10.2
   True Negatives: 6053 cases
     Avg combined gene targets: 5.4 ± 10.5

4. ORGANISM PATTERN ANALYSIS:
   Top false positives organism pairs:
     Humans - Humans: 453 cases
     Humans - Escherichia coli (strain K12): 14 cases
     Escherichia coli (strain K12) - Humans: 7 cases
     Humans - Enteric bacteria and other eubacteria: 4 cases
     Humans - Escherichia coli: 4 cases
   Top false negatives organism pairs:
     Humans - Humans: 140 cases
     Clostridium difficile (strain 630) - Humans: 49 cases
     Bacillus thermoproteolyticus - Humans: 13 cases
     Humans - Bacillus thermoproteolyticus: 11 cases
     Humans - Yeast: 8 cases

5. MOST PROBLEMATIC DRUGS:
   Seratrodast: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Capecitabine: 1.000 error rate
     (2/2 errors: 2 FP, 0 FN)
   Lipoic acid: 1.000 error rate
     (2/2 errors: 2 FP, 0 FN)
   Casirivimab: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   S-(Methylmercury)-L-Cysteine: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Ospemifene: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Lisdexamfetamine: 1.000 error rate
     (3/3 errors: 3 FP, 0 FN)
   Ridogrel: 1.000 error rate
     (2/2 errors: 2 FP, 0 FN)
   Vosoritide: 1.000 error rate
     (3/3 errors: 3 FP, 0 FN)
   Anidulafungin: 1.000 error rate
     (2/2 errors: 2 FP, 0 FN)

6. SPECIFIC ERROR EXAMPLES:
   False Positives (predicted interaction, but no real interaction):
     1. Ceruletide + Bromodiphenhydramine
        Organisms: Humans - Humans
        Gene targets: 1 - 1
     2. Paclitaxel + Aplyronine A
        Organisms: Humans - Humans
        Gene targets: 6 - 1
     3. Ocriplasmin + Pyrantel
        Organisms: Humans - Humans
        Gene targets: 3 - 2
     4. Gilteritinib + Exemestane
        Organisms: Humans - Humans
        Gene targets: 19 - 1
     5. Salsalate + Valpromide
        Organisms: Humans - Rhodococcus erythropolis
        Gene targets: 2 - 1
   False Negatives (missed real interactions):
     1. Phenol + Atenolol
        Organisms: Bacillus thermoproteolyticus - Humans
        Gene targets: 2 - 2
     2. Phenol + Baclofen
        Organisms: Bacillus thermoproteolyticus - Humans
        Gene targets: 2 - 3
     3. Phenol + Nadolol
        Organisms: Bacillus thermoproteolyticus - Humans
        Gene targets: 2 - 2
     4. Phenol + Perphenazine
        Organisms: Bacillus thermoproteolyticus - Humans
        Gene targets: 2 - 3
     5. Phenol + Pindolol
        Organisms: Bacillus thermoproteolyticus - Humans
        Gene targets: 2 - 5

7. SUMMARY INSIGHTS:
   - Model tends to over-predict interactions (more false positives than false negatives)
   - High sensitivity but lower precision - good at catching interactions but with some false alarms

Report generation completed successfully.
============================================================
